Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
Archive

All stories

872 stories in Federal Policy · Page 39 of 44

Tuesday, June 23 · 3 stories

  1. Federal Policy

    Trump Administration Holds $2 Billion in HHS Grants Pending White House Review

    The Trump administration has instituted a multi-step political review process requiring White House OMB approval for all HHS grant funding opportunities, delaying over $2 billion in congressionally appropriated funds. The process includes AI screening for flagged keywords like "harm reduction" and "gender," followed by political review at multiple levels through HHS Secretary RFK Jr.'s office and OMB. CDC delayed $728 million across 30 grants and SAMHSA held $286 million. State and local health departments, which receive approximately 25% of their funding from federal grants, face service cuts if delays continue. The policy applies to all FY 2026 funding opportunities including 988 suicide hotline expansion, outbreak response, and opioid treatment programs.

    spotlightpa.org · 151 days ago
  2. Federal Policy

    Supreme Court Could Review Executive Order Ending Birthright Citizenship

    An opinion piece argues that if the Supreme Court upholds a recent executive order ending birthright citizenship, the policy could create significant public health consequences. The analysis suggests potential impacts on healthcare access and population health outcomes. The piece frames the issue through bioethics and public health lenses. No specific timeline for Supreme Court review is provided in the available content.

    STAT News · 151 days ago
  3. Federal Policy · MN

    New Federal Medicaid Rules Threaten Minnesota Mental Health System

    New federal Medicaid regulations implementing provisions of the 2025 Congressional Budget Reconciliation Bill are set to impact Minnesota's mental health system. The regulations could affect the state's decades-long efforts to build a recovery-oriented mental health system focused on community integration and employment support. The changes appear to limit or restructure mental health coverage in ways that could disrupt existing service delivery models. Managed care organizations operating mental health programs in Minnesota will need to prepare for these changes.

    minnesotareformer.com · 151 days ago

Monday, June 22 · 2 stories

  1. Federal Policy

    White House Proposal Threatens Federal Funding for Health Equity Research

    A new White House proposal could disqualify significant portions of health disparities research from federal funding eligibility. Health equity researchers characterize this as potentially the most serious threat to their field's future. The proposal would subject health equity studies to heightened scrutiny in federal grant review processes. The change would affect how agencies like NIH and AHRQ evaluate research focused on racial, ethnic, and socioeconomic health disparities.

    STAT News · 152 days ago
  2. Federal Policy

    Congressional Democrats Push to Repeal CMS WISeR Model

    Congressional Democrats have introduced legislation to repeal the Transforming Maternal Health (TMH) Model, commonly known as WISeR (Women in States Earning Rewards). The mandatory payment model, which ties Medicaid reimbursement to quality metrics for maternal health services, has faced criticism since its launch. Policy experts say the repeal effort's success remains uncertain given the current political landscape. If repealed, states and managed care organizations participating in the model would see changes to their maternal health payment structures and quality reporting requirements.

    MedCity News · 152 days ago

Friday, June 19 · 1 story

  1. Federal Policy

    Federal Grant Delays Threaten Disability Research Institutions and Services

    Federal agencies have delayed issuing grants to disability research institutions nationwide, creating uncertainty about program continuity and employment. The delays affect research centers that study and support services for people with disabilities, including those enrolled in Medicaid long-term services and supports. No timeline has been provided for when grant awards will resume. The disruption threatens institutional stability and could interrupt data collection and technical assistance that state Medicaid programs rely on for LTSS policy development.

    STAT News · 155 days ago

Thursday, June 18 · 4 stories

  1. Federal Policy

    Senate Democrats Investigate HHS Changes to Federal Vaccine Advisory Panel

    Senate Democrats Ron Wyden and Maggie Hassan have launched an investigation into Health Secretary Robert F. Kennedy Jr.'s restructuring of the Advisory Committee on Immunization Practices (ACIP), the federal panel that issues vaccine recommendations. The senators are demanding communications and records showing who determined the legal and public health consequences of remaking the advisory committee. ACIP recommendations typically inform Medicaid and CHIP coverage decisions for vaccines under the Vaccines for Children program and mandatory coverage requirements for pediatric vaccines. The investigation seeks transparency around the decision-making process that led to changes in the federal vaccine policy infrastructure.

    The Hill · 156 days ago
  2. Federal Policy

    CMS Seeks Input on PBM Compensation Restrictions and Data Reporting for 2028 Implementation

    CMS issued a request for information on pharmacy benefit manager compensation structures and business practices to inform implementation of new legislative requirements. The RFI focuses on two mandates taking effect in 2028: restrictions on remuneration PBMs and affiliates may receive for services related to Part D drug utilization, and new data reporting requirements. CMS is seeking technical input on PBM service arrangements, affiliate relationships, and compensation models. Comments will shape how CMS defines permissible PBM compensation and structures data collection requirements for Medicare Part D plans.

    Federal Register · 156 days ago
  3. Federal Policy

    CDC Reports 1,415% Increase in Nitazene Overdose Deaths Since 2020

    The CDC reported nitazene-involved overdose deaths increased from 27 in 2020 to 409 in 2024, marking a 1,415% rise in confirmed fatalities from these super-potent synthetic opioids. Nitazenes are spreading across the U.S. drug supply, often mixed with or sold as other substances. The sharp escalation indicates an emerging public health threat requiring enhanced overdose response capacity. This trend follows patterns seen with fentanyl's emergence in the illicit drug market over the past decade.

    STAT News · 156 days ago
  4. Federal Policy

    Trump Administration Finalizes Rule Tightening Medicaid Work Requirement Medical Exemptions

    The Trump Administration finalized a rule that restricts medical frailty exemptions from the Medicaid work requirement enacted in the 2025 reconciliation law. The rule narrows exemptions for blindness, disability, substance use disorder, disabling mental disorders, and physical, intellectual, or developmental disabilities that impair ability to perform daily activities. The work requirement takes Medicaid coverage from enrollees who do not meet the requirement and do not qualify for an exemption. The rule takes effect July 31, 2026, and states must apply the requirement to coverage on or after January 1, 2027.

    cbpp.org · 156 days ago

Wednesday, June 17 · 3 stories

  1. Federal Policy

    HHS Announces $708 Million in Behavioral Health Funding Opportunities

    HHS Secretary Robert F. Kennedy, Jr. announced $708 million in new funding opportunities for behavioral health programs, including $96 million for the STREETS (Safety Through Recovery, Engagement, and Evidence-based Treatment and Support) program targeting mental illness, addiction, and homelessness, plus $612 million for additional behavioral health initiatives. The funding opportunities are now posted and available for application. This represents significant new federal investment in community-based behavioral health infrastructure and services that Medicaid managed care organizations often coordinate or deliver.

    SAMHSA · 157 days ago
  2. Federal Policy

    Uninsured Population Grew in 2024, First Increase Since 2019

    The number and share of Americans without health insurance increased in 2024, marking the first rise since 2019, according to KFF's analysis of American Community Survey data. The growth in uninsured individuals follows the end of Medicaid continuous enrollment protections that expired in March 2023, resulting in millions of eligibility redeterminations across states. The increase reverses a five-year trend of declining uninsurance rates and signals potential coverage losses that disproportionately affect low-income populations eligible for Medicaid. This shift has immediate implications for uncompensated care costs and emergency department utilization that MCOs and safety-net providers must absorb.

    KFF Research · 157 days ago
  3. Federal Policy

    FDA Approves Third Over-the-Counter Naloxone Nasal Spray

    The FDA approved Rextovy, a 4mg naloxone nasal spray, for over-the-counter sale in pharmacies, convenience stores, and online for emergency treatment of opioid overdose. This is the third OTC naloxone product approved by FDA. The approval expands consumer access to overdose reversal medication without a prescription. For Medicaid managed care organizations, this may affect pharmacy benefit management, member education strategies, and harm reduction program design, particularly for plans serving populations with substance use disorders.

    The Hill · 157 days ago

Tuesday, June 16 · 7 stories

  1. Federal Policy

    CMS Proposes Rule to Codify Medicare Drug Price Negotiation Program

    CMS has issued a proposed rule to codify the Medicare Drug Price Negotiation Program and establish new policies for both the Negotiation Program and the Medicare Prescription Drug Benefit Program as required by the Inflation Reduction Act of 2022. The rule also proposes modifications to the fixed combination drug policy. The Negotiation Program allows Medicare to negotiate prices for certain high-cost drugs, which could affect formulary dynamics and pricing strategies for Medicare Advantage plans that include prescription drug coverage. The proposed rule sets the framework for how negotiated prices will be implemented and administered.

    Federal Register · 158 days ago
  2. Federal Policy

    NHeLP Report Finds Electronic Asset Verification Creates Rural Medicaid Access Barriers

    The National Health Law Program released a report examining how electronic asset verification systems in Medicaid create enrollment barriers for rural residents, particularly Black rural populations. The report identifies gaps in rural banking infrastructure and property transfer documentation that interfere with automated eligibility systems. The analysis focuses on how Medicaid agencies' reliance on electronic verification tools may disproportionately delay or deny coverage for applicants in areas with limited financial institution networks and informal property arrangements. The report provides recommendations for state Medicaid programs to address these verification challenges.

    National Health Law · 158 days ago
  3. Federal Policy

    Medicare Coverage of Anti-Obesity Drugs Begins Next Month Under Temporary Program

    Medicare will begin covering weight loss medications starting next month through a program designed as temporary but expected to face political pressure for permanence. The coverage represents a significant policy shift for Medicare, which has historically excluded anti-obesity drugs from its formulary. The program's implementation comes as GLP-1 medications like Wegovy and Zepbound have demonstrated clinical efficacy for weight management but carry substantial cost implications. While positioned as temporary, the coverage expansion may prove difficult to reverse once beneficiaries begin accessing these medications.

    STAT News · 158 days ago
  4. Federal Policy

    Senate Democrats Release Prescription Drug Pricing Policy Blueprint

    Senate Democrats released a policy blueprint proposing measures to lower prescription drug costs ahead of the midterm elections. The proposals aim to address voter concerns about drug affordability and provide a counter-message to White House voluntary pricing initiatives. The blueprint reflects ongoing bipartisan interest in drug pricing reform but does not specify legislative text, implementation timelines, or comment periods. For Medicaid managed care organizations, potential reforms could affect pharmacy benefit management, capitation rate calculations, and prescription drug rebate programs.

    The Hill · 158 days ago
  5. Federal Policy

    MACPAC June 2026 Report Addresses Prior Authorization Automation and Managed Care Accountability

    The Medicaid and CHIP Payment and Access Commission (MACPAC) released its June 2026 Report to Congress with recommendations on six policy areas affecting Medicaid managed care operations. The report addresses automation in prior authorization processes, managed care accountability measures, and access to residential treatment services, among other topics. The recommendations also cover community engagement requirements, services for youth with special health care needs, and the Program of All-Inclusive Care for the Elderly (PACE). These recommendations typically inform congressional legislation and CMS policy development over the following 12-24 months.

    MACPAC · 158 days ago
  6. Federal Policy · CO

    FDA Approves Colorado Drug Importation Plan from Canada

    The FDA approved Colorado's Section 804 importation program, allowing the state to import certain prescription drugs from Canada to reduce costs for residents. This marks the first operational approval under the 2020 FDA guidance that permits states to seek authorization for Canadian drug importation. The approval comes after years of state planning and federal review. Colorado must now finalize vendor contracts and operational logistics before importing drugs, with implementation timeline still uncertain.

    STAT News · 158 days ago
  7. Federal Policy

    HHS Secretary Kennedy Demands Explanation for Retracted Vaccine-SIDS Study

    HHS Secretary Robert F. Kennedy Jr. sent a June 11 letter to the editor-in-chief of Toxicology Reports demanding justification for the removal of a 2021 study linking vaccines to sudden infant death syndrome. Kennedy has cited this research in support of proposed changes to childhood immunization schedules. The retraction raises questions about the scientific basis for potential federal policy shifts affecting Medicaid-covered pediatric vaccine programs. No timeline has been announced for HHS policy changes to childhood vaccination requirements.

    The Hill · 158 days ago

Get the daily briefing.